2873 Stock Overview
Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of new Chinese patent medicines for various diseases in China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 1/6 |
Guiyang Xintian Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥11.44 |
52 Week High | CN¥15.24 |
52 Week Low | CN¥7.59 |
Beta | -0.12 |
1 Month Change | -8.41% |
3 Month Change | 6.32% |
1 Year Change | -16.56% |
3 Year Change | 28.27% |
5 Year Change | 31.20% |
Change since IPO | 43.79% |
Recent News & Updates
Shareholder Returns
2873 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 2.3% | 3.3% | -0.3% |
1Y | -16.6% | -14.4% | -14.6% |
Return vs Industry: 002873 underperformed the CN Pharmaceuticals industry which returned -14.4% over the past year.
Return vs Market: 002873 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
2873 volatility | |
---|---|
2873 Average Weekly Movement | 10.5% |
Pharmaceuticals Industry Average Movement | 7.6% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002873's share price has been volatile over the past 3 months.
Volatility Over Time: 002873's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 1,958 | Da Lun Dong | www.gyxtyy.com |
Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of new Chinese patent medicines for various diseases in China. The company offers formulation products, which include hard capsules, granules, tablets, mixtures, syrups, liquors, dews, powders, suspensions, and gels.
Guiyang Xintian Pharmaceutical Co.,Ltd. Fundamentals Summary
2873 fundamental statistics | |
---|---|
Market cap | CN¥2.62b |
Earnings (TTM) | CN¥80.87m |
Revenue (TTM) | CN¥953.98m |
32.6x
P/E Ratio2.8x
P/S RatioIs 2873 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2873 income statement (TTM) | |
---|---|
Revenue | CN¥953.98m |
Cost of Revenue | CN¥219.39m |
Gross Profit | CN¥734.59m |
Other Expenses | CN¥653.72m |
Earnings | CN¥80.87m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 27, 2024
Earnings per share (EPS) | 0.35 |
Gross Margin | 77.00% |
Net Profit Margin | 8.48% |
Debt/Equity Ratio | 52.9% |
How did 2873 perform over the long term?
See historical performance and comparison